Eplerenone for the Treatment of Central Serous Chorioretinopathy

NCT01990677 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

108

Enrollment

OTHER

Sponsor class

Conditions

Central Serous Chorioretinopathy

Interventions

DRUG: 25mg Eplerenone
DRUG: Placebo

Sponsor

Wills Eye

Collaborators

[object Object]